








The Centers for Disease Control and Prevention estimates that each year at least two million people acquire infections from antibiotic resistant bacteria and more than 23,000 of these individuals die due to these infections. While there are numerous studies regarding antibiotic resistance in humans, few are focused specifically on the connection between antibiotic use in food animals and poor human health outcomes.  This paper reviews and summarizes literature and public information currently available as well as legal measures in place to mitigate the threat of resistance due to consumption of food animals contaminated with antibiotic resistant bacteria.  Regulation and monitoring of appropriate antibiotic use in food animal production is of high public health importance to improve human health, reduce medical costs to those in need of antibiotic resistance therapy, and reduce risk of antibiotic resistant bacteria infections in humans.
TABLE OF CONTENTS
 TOC \o "2-4" \h \z \t "Heading 1,1,Appendix,1,Heading,1" 1.0	Introduction	1
1.1	Paper Objective	6
2.0	BACKGROUND	8
2.1	Proposed Food and drug administration regulations	8
2.1.1	Salmonella Enerditis From Contaminated Shell Eggs	9
2.1.2	Final Guidance 213	9
2.1.3	Proposed Rule: “Veterinary Feed Directive”	10
2.2	HOW BACTERIA BECOME RESISTANT	11
2.3	The Cost of Antimicrobial Resistance	13
2.4	WHY USE ANTIBIOTICS IN LIVESTOCK	15
2.5	HOW ANTIBIOTIC USE IN LIVESTOCK IS HARMFUL TO HUMANS	15
2.5.1	Increased Human Morbidity	16
2.5.2	Increased Human Morbidity	17







4.1.2	Staphylococcus Aureus Transmission Between Animals And Humans And Methicillin-Resistant S. Aureus (MRSA)	25
4.1.3	Genetic Assessment of Multi-Drug Resistant (MDR) Salmonella Isolates From Animals, Food, and Humans in the U.S. and Canada	26
4.1.4	Increase in Resistance to Ceftriaxone and Nonsusceptibility to Ciprofloxacin and Decrease in Multidrug Resistance Among Salmonella Strains, United States, 1996-2009	28
4.1.5	What Other Countries Have Done-Denmark	29
4.1.6	Prudent Usage of Antibiotics to Combat Mastitis Pathogens in Dairy Cows		30




5.3	Financial Constraints on producers	34
5.4	Financial Constraints on Consumers	35
5.5	Importance of Antibiotic Preservation	35
5.6	policy Proposal	36
5.7	A Call for More Research	37
5.8	Law Proposal	38
6.0	CONCLUSION	40




 TOC \h \z \c "Table" Table 1. Multiple Drug Resistance of Three Salmonella Serotypes, 1996-2009	28
List of figures
 TOC \h \z \c "Figure" Figure 1. Flow Chart of Antibiotic Resistance Spread	2
Figure 2.  Sale of Antibiotics to Food Animal Producers and Unhealthy Humans from 2001-2011	5
Figure 3. Possible Spread of Antibiotic-Resistant Bacteria from Animals to Humans	12
Figure 4. Financial Burden of Treatment of Antibiotic Resistance	14
Figure 5. The Human Health Impact of Antimicrobial Resistance in Animal Populations	16
Figure 6. Timeline of Observed Antibiotic Resistance Relative to Antibiotic Introduction	19











When Alexander Fleming introduced penicillin to the world, he cautioned humankind about the potential risks of antibiotic resistance for overall human health. Unfortunately, Fleming’s prediction came to fruition as the World Health Organization (WHO) announced in 2014 resistance to antimicrobial agents as a globally significant threat to public health with the United States alone having an estimated two million infections and 23,000 deaths yearly due to antibiotic resistant pathogens ().





Figure 1. Flow Chart of Antibiotic Resistance Spread
    Source: CDC Get Smart: Know When Antibiotics Work


This resistance observed in humans not only results in prolonged infection and additional therapy with stronger, more toxic antibiotics, but it can lead to much more serious outcomes, including death.  The CDC estimated almost half a million infections in the United States due to Clostridium difficile (C. diff) infection in 2011. Of these infections, 29,000 patients died within 30 days of diagnosis.  This infection leads to long hospital stays for treatment and extreme discomfort in those infected. The only way to prevent C.diff infection and antibiotic resistance is to limit prolonged exposure to antibiotics.

Farmers discovered in the 1950s that, for unknown reasons, low doses of antibiotics made their livestock rapidly gain weight when added to their feed.  This led to an increase of antibiotic usage in livestock food animals () and as the United States Department of Agriculture reported in 2012, “…over 32 million pounds of antibiotics sold in the United States were for food animals, a 16 percent increase since 2009” ().

The threat of overuse is described by Michigan State University’s website for veterinary public health:
Epidemiological and molecular observations have shown that AMR in animal populations can increase AMR problems among human populations. For example, vancomycin resistant enterococci (VRE) in both animals and people have become prevalent in countries that used a glycopeptide growth promotant called avoparcin, which is structurally similar to vancomycin.  Vancomycin is a very important antibiotic in human medicine that is often used a last line of defense for several types of infectious agents.  The banning of avoparcin’s use in animals was followed by a rapid subsequent decline in the incidence of VRE in both human and animal populations.  However, VRE in Europe has not disappeared ().

Though there is acceptance and understanding that biomagnification, the accumulation of toxins through consumption of plants or animals high in said toxins, is evident in marine life through the cycle of the food chain in terms of mercury concentrations, there has been little discussion or call to action when it comes to land animals that we eat and from which we gain nutrients. Doctors advise pregnant women to abstain from eating raw and cooked fish, particularly large marine animals as they are high in mercury, but there is no conversation with patients regarding antibiotic/hormone-free dairy products and meat.  The American Academy of Pediatrics recognizes the harm to humans associated with the nontherapeutic use of antibiotics in livestock animals and recommend consuming organic foods:

Between 40% and 80% of the antimicrobial agents used in the United States each year are used in food animals, three-quarters of which is nontherapeutic.  Many of these agents are identical or similar to drugs used in humans.  Evidence is clear that such nontherapeutic use promotes the development of drug-resistant organisms in the animals and that these organisms then colonize the intestines of people living on farms where this practice occurs.  Evidence is also ample that human disease caused by antibiotic-resistant organisms spread through the food chain.  Because organic farming prohibits the nontherapeutic use of antibiotic agents, it could contribute to a reduction in the threat of human disease caused by drug-resistant organisms ().

The excess of antibiotics used in food animals not to treat illness but to promote growth and mitigate the negative effects of livestock overcrowding and unsanitary conditions has raised concern and led to tracking and monitoring by interest groups.  The Pew Campaign on Human Health and Industrial Farming (of the Pew Charitable Trusts) tracked the sale of antibiotics for human therapeutic use as well as for animal production from 2001-2011. It was found that human sale remained consistent; however, antibiotics for use in food production steadily increased to quadrupling that which was sold to unhealthy humans to treat illness. Figure 2 below shows this increase in antibiotic sales to food animal producers.

Figure 2.  Sale of Antibiotics to Food Animal Producers and Unhealthy Humans from 2001-2011
Source: The Pew Campaign on Human Health and Industrial Farming


The CDC summarizes why antibiotic use in livestock animals is harmful to human health:
The germs that contaminate food can become resistant because of the use of antibiotics in people and in food animals.  For some germs, like the bacteria Salmonella and Campylobacter, it is primarily the use of antibiotics in food animals that increases resistance.  Because of the link between antibiotic use in food-producing animals and the occurrence of antibiotic-resistant infections in humans, antibiotics that are medically important to treating infections in humans should be used in food-producing animals only under veterinary oversight and only to manage and treat infectious disease, not to promote growth ().

1.1	Paper Objective
Though overuse of antibiotics in humans has become a topic of concern in medical and public health communities in recent years, antibiotic use in livestock animals has yet to receive equal attention.  Just as with humans, animals gain antibiotic resistance with constant exposure to low doses of antibiotics and become a reservoir for stronger more pathogenic bacteria.  Contact with and consumption of these food animals exposes humans to these superbugs and introduces resilient bacteria to a human host leading to infection and need for stronger, more toxic antibiotics to combat the illness.  This paper aims to review available articles and public information on antibiotic use in food animals and proposes policy change to enforce compliance among food animal producers.

The first chapter summarizes current industry standards for appropriate antibiotic use in livestock as well as drug manufacturer guidelines. In addition to current policy standards, the process by which antibiotic resistance occurs in humans and animals is discussed as well as the cost of therapy for antibiotic resistance in humans.  The first chapter also details why antibiotics are used in production of food animals and profit to veterinarians who provide antibiotics to farmers. 

Chapter two explains the process by which literature and articles used in this paper were found and assessed for validity.  Specifics regarding sources and terminology used in databases are detailed and justified.  Additionally, selection and exclusion criteria are explained to afford clarity to the reader as to timeline and focus of the studies and articles chosen for this paper.

The third chapter contains summarizes reviews and articles relating to antibiotic use in food animals and the impact on human health; the fourth chapter discussing the findings of the literature and limitations encountered.  This chapter also explains gaps in literature and information as well as weaknesses in current policy.

The sixth and final chapter proposes policy change to ensure food animal producer compliance for appropriate use of antibiotics in their livestock.  The proposed law includes a timeline for complete arrest of non-therapeutic antibiotic use in food animals with incentives for early procedure changes by the producers.  The sixth chapter also expresses the need for more research focusing on antibiotic use in food animals and the direct health impact on humans.  
2.0 	BACKGROUND
2.1	Proposed Food and drug administration regulations
Numerous surveys conducted by the United States Department of Agriculture (USDA) found that animal food production facilities that operate on an industrial scale often administer antibiotics to their healthy livestock at low doses for the purposes of faster growth promotion and mitigating the effects of poor sanitation and overcrowding. Administration of antibiotics to healthy animals for non-therapeutic purposes has been definitively linked to the public health crisis of human antibiotic resistance ().

Under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act the Food and Drug Administration (FDA) has the authority to make and enforce regulations that “…are necessary to prevent the introduction, transmission, or spread of communicable disease from foreign countries into the States…or from one State…into any other state” ().  This language mirrors authority given to the federal government under the Commerce clause of the United States Constitution.
2.1.1	Salmonella Enerditis From Contaminated Shell Eggs
In light of numerous outbreaks of Salmonella eneriditis (SE) due to contamination from shell eggs, the FDA and CDC proposed in 2013 mandatory regulations to reduce SE contamination.  These outbreaks came in many forms but each occurred from undercooked SE contaminated eggs.  The cases ranged from hollandaise sauce that was not brought to a sufficient temperature causing the SE to proliferate to a homemade cheesecake where the eggs were undercooked.  Without proper heating of food containing SE the bacteria will continue to survive and spread to a human host through consumption.
2.1.2	Final Guidance 213
In 2013 the FDA, CDC, and USDA testified before Congress to address the crisis of antibiotic resistance in humans, as there is a link between nontherapeutic, routine antibiotic use in production of food animals.  To address this concern, the FDA issued a final industry guidance, Final Guidance 213, to define appropriate antibiotic use in food animals in hopes of curbing the antibiotic resistance crisis ().

First and foremost the guidance defines appropriate therapeutic antibiotic use in food animals for the “treatment, control, and prevention of specific diseases…necessary for assuring the health of food-producing animals” () and establishes criteria for the justification of antibiotic use in food animals for disease prevention only.  The majority of Guidance 213 applies to drug companies, allowing them to remove growth promotion as a use on labels. It also allows for changes in marketing status on product labels without having to include further effectiveness and safety data provided there is no change to the chemical makeup of the product nor new uses for treatment (). This means drug companies can remove growth promotion of livestock animals from the label immediately without having to halt production to allow for FDA investigation and approval of the new label. Also included is guidance for veterinarians and food animal producers that prescribed drugs must have specific dose levels and duration for an identified disease. Also, and most importantly, drugs can be prescribed for only certain diseased animals, not an entire flock or herd ().  Although this is an important step in the direction of judicious antibiotic prescribing and usage practices, FDA guidance is voluntary, not mandatory. 
2.1.3	Proposed Rule: “Veterinary Feed Directive”
In addition to the FDA’s issuing the Final Guidance 213, a draft rule was also developed to provide clarity and simplicity.  The proposed rule was written in conjunction with Guidance 213 and allows use of certain antibiotics in animal feed for medically important issues as specified under required veterinary feed directives (VFD).  A proposed rule is an official document announcing and explaining an agency’s, in this case the FDA, plan for addressing a problem.  The rule aims to streamline existing requirements and administrative procedures as well as reduce record-keeping requirements so as to support transition of animal antibiotics into the VFD system ().  Additionally, states would receive authority to define the veterinarian-client-patient relationship.  This is necessary as part of the VFD directives to allow veterinarians to prescribe drugs to animals within the production facility. Lastly, the directive set a default expiration date of six months unless otherwise indicated for all veterinary drugs prescribed ().
2.2	HOW BACTERIA BECOME RESISTANT 
In the case of resistance due to antibiotic use in food animals, antimicrobial resistance to bacteria occurs due to the similarity in the structure of the components in the antibiotics used in humans and animals.  For example, avoparcin is used extensively in livestock animals and is structurally similar to vancomycin, which is used in hospitals as a treatment for severe infections.  The result of overusage and similarity to one another led to the emergence and spread of vancomycin resistant enterococci (VRE) in hospitals.  This is a specific drug resistance but the cross-recognition and cross-resistance that occur with resistant bacteria allow them to be resistant to most, if not all, antimicrobial therapies within the same class, some of which are important for human therapy.  

Bacteria rapidly undergo what is called horizontal gene transfer (HGT), which is how a new bacterium acquires resistance. During HGT bacteria pass between each other mobile genetic elements containing antimicrobial resistant genes (ARG) in addition to other functional genes.  This along with the rapid process of HGT allows for expeditious microorganism growth and passage of genetic components and advantageous mutations (). Figure 3 below depicts the possible spread of antibiotic resistant bacteria from animals to humans.






2.3	The Cost of Antimicrobial Resistance




Figure 4. Financial Burden of Treatment of Antibiotic Resistance

Since the discovery of antibiotics in the 1940s, deaths and illnesses due to infectious diseases have greatly declined (). But with every action comes a consequence as explained by the Federal Interagency Task Force on Antimicrobial Resistance:
The extensive use of antimicrobial drugs has resulted in drug resistance that threatens to reverse medical advances of the past 70 years ().

In response, CDC along with others have worked with doctors and patients alike to encourage judicious and responsible antibiotic prescribing methods.  However, the majority of prescribed antibiotics are administered to farm animals and little has been done as of yet to reduce antibiotic usage in food production environments.
2.4	WHY USE ANTIBIOTICS IN LIVESTOCK
In an attempt to meet the protein needs of a growing human population, animal food farms became large and sought new production processes to maximize the growth rates of their animals.  These increased growth and production rates helped to make food protein more available and affordable to this growing population as well as maximized profit to the producer.  Increased production rates also increased the need for more livestock.  An increase in livestock then led to unsanitary conditions and disease in the animals, prompting producers to administer constant low doses of antibiotics to their animals as a prophylactic to prevent disease. However, the use of antibiotics in food production also led to the spread and development of antimicrobial resistance (AMR) (; ) .  
2.5	HOW ANTIBIOTIC USE IN LIVESTOCK IS HARMFUL TO HUMANS









As infectious agents survive, grow, and gain AMR traits inside their animal reservoirs, they get stronger and increasingly more resistant to antimicrobial treatments.  Their increased strength against antimicrobial therapies is due to their constant exposure to and survival of low doses of commonly used antibiotics used for human illnesses. This leads to dominance of the AMR bacteria over prevailing microflora within the animal host, leading to increased transmission of the AMR genes as opposed to susceptible, unexposed and non-resistant bacterial strains.  Of particular importance, zoonotic agents, those that can be transferred between animals and humans, within animal reservoirs with AMR bacteria prevent antibiotics used for their treatment, control, and prevention from being effective, thus allowing for the spread of these ‘super’ bugs to other animals and humans ().

Salmonella, Campylobacter, and E. coli are linked to the use of antibiotics in food animals as found by the Department of Health and Human Services (HHS), FDA, and CDC (). These organisms are three of the top five major foodborne agents that account for an estimated 90% of deaths resulting from infection with foodborne pathogens in the United States.  Most reports connect these increasing trends to the subtherapeutic use of antimicrobial therapies in poultry and livestock ().

2.5.2	Increased Human Morbidity
A doctor-prescribed empirical treatment occurs when a patient presents with an infection for which immediate treatment is necessary and laboratory confirmation would not prove timely.  These treatments are considered the first line of defense and involve common, broad-spectrum antibiotics.  Sometimes, however, an infection proves resistant to these empirical treatments and can actually gain strength after exposure to an antibiotic to which it is resistant.  The weaker bacteria within the host die off following exposure and the stronger, resistant bacteria flourish and reproduce. Some examples when this has occurred are the failure of quinolones in treatment of salmonellosis and the failure of vancomycin in managing nosocomial VRE.  When this occurs, more expensive, toxic narrow-spectrum antibiotics are required.  These “last line of defense” antibiotics are not only expensive but their toxicity leads to great stress on the human body leaving the patient incredibly ill and unwell.  Even with their strength and toxicity, these strong antibiotics are now documented as ineffective in treatment of bacterial strains seen in ill patients, for example, in the case of therapeutic failure in the treatment of methicillin-resistant Staphylococcus aureus (MRSA)  ADDIN EN.CITE ().  When this occurs the infection becomes fatal and the host is lost to the agent ().  Below is a timeline from CDC’s website showing the emergence of resistance of specific antibiotics in relation to their introduction to the human population.

Figure 6. Timeline of Observed Antibiotic Resistance Relative to Antibiotic Introduction
Source: CDC Antibiotic/Antimicrobial Resistance
2.5.3	The Impact of Antimicrobial Resistance in the Developing World




This essay is based on a review of literature. Studies were included in this review if they were performed within the last five years with a cutoff of 2011 and pertained to antibiotic usage in livestock and/or potential or exhibited harm to humans due to said antibiotic usage.  The determination of ‘harm’ includes but it not limited to, compromised health outcomes, or risk due to close contact with livestock, risk due to consumption of livestock animals or their byproducts (e.g. milk, eggs).  Articles, studies, and information included in this essay pertain only to the United States and Canada.
3.2	Search Strategy
The rapid search was conducted using PUBMED’s database for archived publications in medicine, health, and research.  This database was chosen due to its broad coverage of antibiotic-resistance and its impact on human health.  The search included Medical Subject Headings (MeSH) relating to antibiotic resistance in humans, livestock, and animal production practices.  The MeSH terms “antibiotics,” “antimicrobial,” “resistance,”  “growth promotion,” and “antibiotic prophylactic” were combined with terms used for animal food production facilities, such as “farm,” “food animal,” “food production,” and “livestock.”  The terms “antibiotic resistance,” “multi-drug resistance,” and “food animal production” were also used as generic terms to describe antibiotic resistance due to antimicrobial use in livestock.

This rapid review was conducted by one researcher who scanned the titles and abstracts of each study to determine which studies fit the inclusion criteria and purpose of the review.  Once studies were deemed eligible, full-text copies of articles were obtained for full assessment and evaluation of pertinence to the subject matter.

In addition to a database review, a search on the search engine Google was conducted to find all publicly available information as provided by the CDC.  Information available on the CDC Get Smart: Know When Antibiotics Work website provided background information on the scope of the antibiotic-resistance crisis as well as other resources for data extraction, including Michigan State University’s Antimicrobial Resistance Learning Site where information and figures were obtained.

Additionally, on January 25, 2016, the director of the Bureau of Epidemiology for the Pennsylvania Department of Health (PADOH) was contacted for meaningful articles regarding antibiotic use in livestock (see Appendix A).  In addition to his position as the director, Nkuchia M’ikanatha, DrPH, MPH, also runs the Get Smart: Know When Antibiotics Work program for the state of Pennsylvania, a program developed by the CDC to promote judicious antibiotic prescribing practices, including farm use.  For these reasons he was a resource for current and meaningful information regarding antibiotic use in animal production.
3.3	DATA EXTRACTION
Data collected from studies and sources deemed appropriate included study designs, study outcomes, and background information regarding antimicrobial resistance.  Information extracted about study design included specific antibiotics tested, time period studied, and specific bacterial strains studied/identified.  The outcome measures extracted included information on patient health outcomes, infection rates, and suggestions for improvement.
4.0 	RESULTS
Seven articles were determined to be eligible for inclusion in this paper. The studies are summarized below.
4.1.1	Meat Fermentation Disruption
Kjeldgaard, Cohn, Casey, Hill and Ingmer  (2012) sought to determine whether antibiotic levels deemed acceptable for veterinary usage in livestock populations inhibit proper meat fermentation necessary to prevent the production of bacteria that could potentially prove to be pathogenic to humans once consumed.  As processed meats (e.g., salamis and pepperonis) are universally believed to be safe due to lactic acid fermentation allowing for acidification, the researchers aimed to determine whether these commonly believed ‘safe’ foods were, in fact, safe. They chose six common commercially available bacterial starter cultures based on their susceptibility to widely used antibiotics, specifically penicillin, oxytetracycline, and erythromycin.  Within their obtained cultures, statutorily acceptable levels of the latter two antibiotics inhibited meat fermentation in two of the six cultures, thus allowing potentially pathogenic bacteria to survive and ultimately multiply. When the fermentation process is disrupted in meat processing, pathogenic bacteria, such as Escherichia coli O157:H7 and Salmonella enterica serovar Typhimurium, are more likely to survive, multiply and cause human illness  ADDIN EN.CITE (; ).
4.1.2	Staphylococcus Aureus Transmission Between Animals And Humans And Methicillin-Resistant S. Aureus (MRSA)
As MRSA has become a public health concern of increasing interest, it is crucial to understand where these infections begin.  MRSA infections can be acquired in both community and healthcare settings and have emerged as a cause of infection among those who work with livestock and those for which they are in close contact  ADDIN EN.CITE ().  Through phylogenic mapping of sequenced isolates from the United Kingdom (Scotland) and publically accessible genomes of Staphylococcus aureus clonal complex 398 (CC398), clonal sequences found in both humans and livestock, human- and livestock-associated clades were identified and compared against each other to determine whether human-livestock and livestock-human transmission had occurred. It was found that distinct human- and livestock-associated clade transmissions were observed with numerous livestock to human transmission as well as between countries. This clade, or grouping of organisms based on common ancestry, transmission shows that livestock originating bacteria had passed to humans and human originating bacteria had passed to animals, though there were far more livestock to human transfers. 
4.1.3	Genetic Assessment of Multi-Drug Resistant (MDR) Salmonella Isolates From Animals, Food, and Humans in the U.S. and Canada
A study conducted by LaShanda M. Glenn, et al. in 2013 sought to identify genetic elements associated with multi-drug resistant (MDR) Salmonella in order to determine the source of MDR in animals and potential impact on the health of humans  ADDIN EN.CITE (). Salmonella enterica is the dominant cause of foodborne illness worldwide and can be transferred to humans through food products and contaminated water  ADDIN EN.CITE (). One of the most common infections due to foodborne illness globally, S. enterica is responsible for an estimated one million illnesses, nearly 20,000 hospitalizations, and more than 378 deaths each year in the United States alone  ADDIN EN.CITE ().

Though most infections due to Salmonella infections are fairly mild and self-limiting in healthy individuals, invasive Salmonella infections in some individuals, especially those who are immunosuppressed, are far more severe and require antimicrobial therapy.  The severity of the infection, coupled with the need for antimicrobial therapy lends greater concern to the impact on the health of the individual. This concern is because MDR Salmonella is resistant to multiple classes of antibiotics requiring more aggressive treatment for already unhealthy humans.  This exposes their immune system to stronger antimicrobial treatments and, thus, increases their exposure to more powerful antibiotics and increasing their risk for even greater antibiotic resistance.  Increased exposure to these higher classes of antibiotics raises individual risk for subsequent antibiotic resistant infections and development of Clostridium difficile. To determine MDR sources the team worked with the National Antimicrobial Resistance Monitoring System (NARMS) to isolate samples from U.S. slaughter (n=12), retail (n=9), and human (n=9) gene isolates.

The team also worked with the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) to obtain Canadian slaughter (n=9), retail (n=9), and human (n=8) isolates to assay for antimicrobial resistance and MDR plasmid genes. Plasmids are small segments of DNA that can transfer their genetic material to other bacteria conferring a gain of multiple potentially virulent genes to the reviewing bacterium. These plasmids often are the cause of antimicrobial resistance but also contain genes that increase virulence and environmental fitness as well as lend to resistance to heavy metals and sanitizers.  The plasmids of particular interest contain the IncA/C relicon that has been linked to MDR resistance in S. enterica within food animals as well as the fish pathogens Yersinia ruckeri and Y. pestis-the causative agent of plague.  

Their study found the most common serovars, classifications within bacteria that encode cell surface antigens, for U.S. National Antimicrobial Resistance Monitoring System (NARMS) to be Typhimurium, Heidelberg, and Newport for both human and animal isolates and Typhimurium, Heidelberg, and Hadar for retail meat.  For the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS), Typhimurium, Heidelberg, and Enteritidis from humans; Typhimurium, Heidelberg, Hadar, and Sanitpaul from animals; and Typhirium, Heidelberg, and Hadar from retail meat.  The team then chose from the isolates serovars those resistant to the highest number of antimicrobial compounds and tested them to find that all the isolates were resistant to three to 13 compounds with the average resistance to seven compounds.  These results show that in order to understand the spread, cause, and prevalence of MDR Salmonella and the impact on human health; genetic element investigations in combination with phenotypic monitoring are necessary in the future.
4.1.4	Increase in Resistance to Ceftriaxone and Nonsusceptibility to Ciprofloxacin and Decrease in Multidrug Resistance Among Salmonella Strains, United States, 1996-2009
In 2013 Medalla et al. published a study assessing trends of resistance and nonsusceptibility of Salmonella to ceftriaxone and ciprofloxacin, two antimicrobial agents commonly used to treat Salmonella infection.  Salmonellosis is a serious infection commonly transmitted to humans through contaminated food and is of concern as the prevalence of AMR Salmonella has risen in recent years, leading to more hospitalizations, severe infections, and deaths.  The team worked with the CDC’s National Antimicrobial Monitoring System surveillance information to interpret changes in antimicrobial resistance of Salmonella isolates to ciprofloxacin from 1996-2009.  The study showed an increase in ceftriaxone resistance from 0.2% to 3.4% (OR=20, 95% CI 6.3-64) for isolates of nontyphoidal Salmonella and an increase from 0.4% to 2.4% (OR=8.3, 95% CI 3.3-21) for non-susceptibility to ciprofloxacin. Multidrug resistance (MDR), defined as resistance to ≥3 antimicrobial classes, varied as shown below in Table 1:






The observed decrease in MDR for serotype Typhimurium is attributed to an overall decline in the presence of the serotype.  The team concluded that reduction of unnecessary usage of therapeutically important antimicrobial agents in food animals is a requirement as AMR Salmonella is predominantly a direct consequence of antimicrobial usage in livestock  ADDIN EN.CITE ().
4.1.5	What Other Countries Have Done-Denmark
In 1974, Stuart Levy, MD of Tufts University conducted a study on a small farm in Denmark where he introduced oxytetracycline-laced feed to the diets of the chickens on the farm for growth promotion.  The team found within six months those living on the farm also carried tetracycline-resistant coliform bacteria, making up over 80% of their intestinal microbes. Also, the bacteria carried by both the farmers and the chickens displayed traits conferring resistance to, not only the original drug, but multiple other antibiotics.  The researchers then removed the antibiotics from the feed and observed six months following removal the majority of the workers no longer carried bacteria with tetracycline resistance.  This study led to a ban on tetracylines as growth promoters in Europe ().

However, in 1994, a Danish veterinarian, Frank Aarestrup, DVM, found that antibiotics other than tetracyclines were still being administered at an alarming rate by Danish veterinarians. These antibiotics were used for prophylaxis and growth promotion, with 90% of antibiotics administered to poultry at low doses for the purposes of growth promotion. He then found these veterinarians received a third of their income by selling antibiotics to farmers. 

Aarestrup assembled a team to study ARB in the feces of healthy pigs and chickens and found a clear relationship between the use of avoparcin, an antibiotic similar to vancomycin, and widespread ARB ().  The team found that 80% of sampled chickens on farms where avoparcin was used as a growth promoter carried vancomycin-resistant bacteria, whereas no chickens had this same resistance on organic farms tested.  This rise in vancomycin-resistance is important because vancomycin is a last resort treatment for humans with life-threatening infections.   

Denmark responded to these findings first in 1995 by limiting how much veterinarians could profit from the sale of antibiotics as well as becoming the first country in Europe to ban all uses of avoparcin.  Later, in 1999, all nontherapeutic antibiotic use in pigs was outlawed, notable because Denmark is the global leading exporter of pork. The result was a rapid decrease in VRE in the stools of both pigs and healthy humans with little negative impact on Denmark’s pork industry.  It was found that from 1992-2008 though antibiotic use halved, overall productivity increased and pig mortality decreased.  By streamlining their processes and making them more efficient Danish food animal producers are experiencing less disease and higher productivity ().
4.1.6	Prudent Usage of Antibiotics to Combat Mastitis Pathogens in Dairy Cows
Mastitis is a common condition that occurs in dairy cattle in which the udder and mammary glands become inflamed due to infection.  This occurs commonly during periods when the cows are not producing milk and can be a result of contamination from the milking apparatus (). To combat this, penicillin, cephalosporin, streptomycin, and tetracycline are often used as preventative measures during non-milk producing periods.  Though it is understood and recognized that usage of antibiotics in dairy cattle can be potentially harmful to humans consuming milk and meat from these animals, proper dosage and appropriate duration of antimicrobial agents will yield low enough doses of antibiotics for pasteurized milk and properly cooked meat to present negligible risks to humans.  However, consumption of raw milk is becoming increasingly more common thus heightening risk to humans to acquire mastitis infections from the milk as well as other AMR pathogens present due to lack of pasteurization (). For this reason, low dosages of antibiotics for a short duration to unhealthy dairy cattle and consumption of pasteurized milk are recommended to protect human health.
4.1.7	Characterization of Extended-Spectrum Cephalosporin Resistant S. Enterica Serovar Heidelberg Isolated From Food Animals, Retail meat, and Aumans in the United States 2009
In 2012 Folster et al. published a study to explain the 2009 increase in extended-spectrum cephalosporin (ESC) resistance.  Ceftriaxone, a cephalosporin, is an antimicrobial agent used to treat severe salmonellosis.  In that same year, the NARMS conducted surveillance that showed an increase in ESC resistance among Salmonella Heidelberg isolated from slaughtered food animals, retail meat, and humans.  This information prompted Folster and his team to conduct a study to determine if this increase was due to the emergence of a new variant of S. Heidelberg or due to clonal expansion, or the conference of traits from a parent to a daughter cell.  Their study found that the observed rise in ESC resistant Heidelberg in humans and food animal source is not due to a single clone expansion but is likely due to multiple isolated events of ESC resistance acquisition in a serovar associated with poultry where cephalosporins are used. In other words, this ESC resistance developed in food production where chickens were administered Ceftriaxone, and humans eat those chickens and acquired the same resistance  ADDIN EN.CITE ().
4.0 	DISCUSSION
This paper summarizes studies on nontherapeutic antibiotic use in food animals and its potential link to antibiotic resistance in the United States.  Given the national attention paid to the issue of AMR, it is surprising there are not more rigorous studies available with a focus on AMR and antibiotic use in livestock.  Though there are plenty of studies and interventions available targeting downstream improvement, such as how to react when an individual is found to be antibiotic resistant, there is very little available with an emphasis on upstream changes. As antibiotic use in livestock animals is a recent area of focus within the scientific community, more attention should be paid to the issue as it relates to humans.  Overall, these studies did not provide enough information regarding alternatives to antibiotic use in food animals, making it difficult to propose an acceptable intervention that will not harm the animals or humans who eat them.
4.1	STUDY SIMILARITY
Many of the studies used in this review have overlapping objectives and outcomes: farmers use antibiotics unnecessarily, causing humans to acquire and become ill from antibiotic-resistant bacteria.  The most common intervention suggested is to limit antibiotic exposure, which is not a sound intervention without providing alternative practices to mitigate the obstacles presented which led producers to use antibiotics in the first place.  Another avenue is to alter and track how antibiotics are prescribed.  Monitoring and changing prescribing practices will not work without oversight and enforcement nor does a simple suggestion ensure increased provider knowledge on the subject. 
4.2	WEAK LEGAL LANGUAGE
Denmark was successful in its efforts to reduce unnecessary antibiotic use in livestock and improve the health of its people because it had policies to enforce compliance.  The FDA’s attempts to decrease injudicious antibiotic use in livestock animals are based on suggestions and guidelines but not firm standards with penalties for nonobservance.  The language used in the Final Guidance 231 and Draft Rule allows for interpretation and use of loopholes.  Without policy enforcement and monitoring, producers have no incentive to follow guidelines suggested to reduce prevalence of antibiotic resistance in food animal populations.
4.3	Financial Constraints on producers
Modifying a production process is an expensive endeavor and when modification is not required producers likely will not adjust their methods and risk financial deficits.  Without strategies and studies designed to determine how to expedite and streamline the production cost in a financially feasible way while observing suggested antibiotic use guidelines food animal, producers would not know where to start.  More information as to how to reasonably modify current food animal production processes is necessary to begin a large-scale change of operations. Denmark has successfully modified its animal production procedures while achieving greater productivity as well as improved animal and human health; learning its procedures and modifying them to suit the needs of farmers and producers in the United States may prove advantageous.
4.4	Financial Constraints on Consumers
Those struggling financially cannot afford healthier high-priced food items, as organic foods produced without antibiotics often are.  If an aggressive large-scale process alteration were to happen in the food animal production industry cost added to the producer will be passed to the consumer and could potentially lead to food unavailability and, thus, poorer health outcomes.  Though a change in antibiotic use in food animals is needed, it should happen in a manner that does not negatively impact the population producers want to feed.

4.5	Importance of Antibiotic Preservation
The introduction and use of antibiotics reduced death due to infection and treatment of conditions that, in the past, profoundly impacted individual health and the health of communities.  Overuse and injudicious prescribing has reduced the effectiveness of critically important medications to protect human health.  It is of paramount importance that current and future generations experience less exposure to antibiotics to ensure drug efficacy against infections.  A simple and manageable way to reduce exposure, along with provider discretion, is to eliminate the nontherapeutic use of antibiotics in food animals.  Doing so will reduce risk of human exposure to antibiotic resistant bacteria through consumption of contaminated food.
4.6	policy Proposal
As FDA policies currently stand, antibiotic use reduction is voluntary for animal food producers.  The New York Times published an article in October 2014 stating that the United States uses substantially more antibiotics in livestock than many other countries.  For example, Levy compared the United States to Denmark and Norway, two countries that have recognized AMR as a threat and have implemented strategies to reduce usage; the United States uses six times more antibiotics in livestock animals ().  The FDA regulations proposed in 2013 were merely guidelines and voluntary for food animal producers.  Producers can easily circumvent the system as all the regulations ask is for drug companies to change drug labels so as not to state animal growth as a use limiting food producers to obtaining prescriptions for antibiotics in the event of an identified illness in an animal.  If producers want to use antibiotics for the purposes of growth promotion they can simply state they need the antibiotics to prevent illness, thus continuing the cycle.  The only way for meaningful strides to be made to combat the growing problem in the United States of antimicrobial resistance is to impart a law requiring food animal producers to stop usage of antibiotics in healthy populations.  

A law to discontinue antibiotic use in healthy food animal populations would likely be met with resistance as food prices will inevitably rise and producers will be forced to maintain smaller flocks and herds.  For this reason, a stepwise plan with gradual implementation will be necessary for success for all involved.  
4.1	A Call for More Research
In 2014 the WHO issued a report highlighting the global reality of antibiotic failure. A call for more research regarding investigation of antibiotic resistant bacteria (ARB), antibiotic drugs, and ARGs in the environment has been made as there is very little assessing the impact of antibiotic-exposed animals’ wastes in the environment. 
Of special interest are those agrosystems in which antibiotic use is nontherapeutic and mitigation efforts to prevent antibiotics, biologically active degradation compounds (i.e. metabolites), ARB, and ARGs from reaching the environment are limited or nonexistent.  Unlike human biosolids and wastewaters that undergo treatment before land application, it is common for untreated animal waste to be applied to land.  As a result, coordinated full-scale investigations concerning the impact of agroecosystems on the spread of antibiotic resistance in the wider environment are necessary to elucidate the potential influence of these systems on the development, movement, and survival or persistence of ARB and ARGs ().


Currently the effect on human health low level environmental antibiotic and ARB exposure is unknown.  Human antibiotic exposure occurs through various pathways including inhalation of dust particles and consumption of contaminated water and food products.  Long-term effects of chronic human exposure to low levels of antibiotics through environmental interaction and contaminated food consumption remain uninvestigated; however, studies conducted suggest selection for ARGs and/or ARB ().  More research is needed to assess long-term burden to humans due to environmental contamination with ARB and ARGs from antibiotic exposed livestock waste.
4.1	Law Proposal
In light of the potential negative effects on humans of overuse of antibiotics in food animals, this paper proposes a change in policy.  A law that requires American food animal producers to discontinue non-therapeutic antibiotic use in their livestock population within ten years of law passage would help to mitigate the crisis of antibiotic resistance in human in a practical yet established amount of time. This is the hard endpoint for all antibiotic use in livestock for growth promotion and disease prevention.  

For the complete discontinued usage of antibiotics, producers will likely be faced with financial decline, as they will be forced to reduce their herds/flocks.  To offset this negative effect, producers will be offered a tax break for every year they can show a decrease in non-therapeutic antibiotic usage as defined by FDA standards.  Like current FDA guidelines, this evidence of antibiotic reduction will be voluntary, but the complete stoppage of non-therapeutic antibiotic usage at the ten-year mark would be mandatory.  





Figure 7. Percent Subsidy Accrual with Continued FDA Antibiotic Reduction Confirmation

This accrual system encourages producers to begin reducing antibiotic usage from the beginning because they have the opportunity to gain two percent each year on top of the previous year.  If a producer were to wait until the sixth year, he would get two percent whereas a producer who began the first year and continued to prove antibiotic reduction would receive 12 percent in subsidies.  
5.0 	CONCLUSION
Consumer practices have evolved over the recent years to favor foods certified organic with the belief natural, organic foods are healthier.  For livestock to be deemed certified organic the animals must be raised without routine use of growth hormones and antibiotics.  Also, if an animal is treated for a disease using antibiotics it cannot be sold as certified organic.  Since 1997 U.S. acreage devoted to production of organic foods has doubled indicating a greater demand by consumers for natural, antibiotic and hormone-free food stuffs despite the approximate 40% markup associated with organic foods (). Just as the demand for natural foods has risen so should the supply to allow for a reduction in cost to the consumer.  

There is no simple solution to ending injudicious prescribing practices and reducing antibiotic resistance in humans.  This issue has evolved over decades of misuse and abuse of critical medications needed for human health. As such, remedying this problem will be a long and complicated process requiring time and resources to properly intervene and effect a reasonable and feasible solution.

As far back as Fleming’s discovery of penicillin, there has been concern abot the potential risks for antibiotic resistance.  The presence of resistant strains of tuberculosis and other bacteria is evidence that this concern is well founded.  Antibiotic resistance develops with misuse of antibiotics, some of which occurs when producers use medicines to promote growth in food animals.  Very little research exists that explores the connection of the consumption of antibiotic-treated animal food sources with antibiotic resistance in humans.  This paper reviewed the few studies of this sort that do exist.
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